A comparison of general drug utilization in a metropolitan community with utilization under a drug prepayment plan.
作者信息
Greenlick M R, Darsky B J
出版信息
Am J Public Health Nations Health. 1968 Nov;58(11):2121-36. doi: 10.2105/ajph.58.11.2121.
Abstract
摘要
相似文献
1
A comparison of general drug utilization in a metropolitan community with utilization under a drug prepayment plan.
Am J Public Health Nations Health. 1968 Nov;58(11):2121-36. doi: 10.2105/ajph.58.11.2121.
2
Prescription drugs: issues of cost, coverage, and quality.
EBRI Issue Brief. 1999 Apr(208):1-21.
3
Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
Med Care. 2017 Feb;55(2):191-198. doi: 10.1097/MLR.0000000000000630.
4
Examining the drug utilization and expenditures of a medically indigent population.
Inquiry. 1978 Mar;15(1):38-44.
5
By the Numbers. Prescription drugs and supplies.
Mod Healthc. 2001 Dec 24;31(52 Suppl):30.
6
Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Inquiry. 1993 Summer;30(2):199-207.
7
Examining the annual drug utilization of a cohort of low income health plan members.
Med Care. 1979 Jun;17(6):578-91. doi: 10.1097/00005650-197906000-00003.
8
By the numbers. The rising costs of prescription drugs.
Healthplan. 1999 Sep-Oct;40(5):71-2.
9
Reporting of drug expenditures in the MCBS.
Health Care Financ Rev. 2003 Winter;25(2):23-36.
10
Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus.
Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):209-13. doi: 10.1002/pds.2077. Epub 2010 Dec 23.
引用本文的文献
1
The epidemiology of psychotropic drug use in Canada.
Can Fam Physician. 1978 Sep;24:889-92.
2
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.
Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.
3
Economic impact of cost-containment strategies in third party programmes in the US. Part II.
Pharmacoeconomics. 1993 Sep;4(3):187-202. doi: 10.2165/00019053-199304030-00004.
4
The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.
Health Serv Res. 1997 Apr;32(1):103-22.
5
Practitioners and health policy. Case of the Ontario Drug Benefit Plan.
Can Fam Physician. 1995 Dec;41:2053-60, 2070-6.
6
Drug prescription rates before and after enrollment of a Medicaid population in an HMO.
Public Health Rep. 1978 Jan-Feb;93(1):16-23.
本文引用的文献
1
Experience with a prepaid drug benefit.
J Health Hum Behav. 1963;4:14-22.
2
Impact of a reduced-charge drug benefit in a prepaid group practice plan.
Public Health Rep (1896). 1966 Oct;81(10):938-40.
Zotero 插件